Scientists Discover Molecule That Promotes Slimming Without Diet and Aussie Researchers Find New Way to Target Sugar Directly, Forget Ozempic

Scientists have identified a naturally occurring molecule that suppresses appetite and promotes weight loss without the side effects commonly associated with current obesity treatments like Ozempic, according to recent research from Stanford Medicine and corroborated by independent studies.

The molecule, identified as BRP (a peptide derived from prohormone processing), acts specifically in the hypothalamus—the brain region responsible for regulating appetite and metabolism—offering a more targeted approach than existing GLP-1 agonist drugs such as semaglutide (marketed as Ozempic and Wegovy).

In animal studies, BRP reduced food intake and body weight while avoiding nausea, constipation and significant muscle loss—side effects frequently reported with semaglutide use. Researchers noted that because semaglutide receptors are present in the gut, pancreas, and other tissues, its effects are widespread, whereas BRP appears to act primarily in the brain’s appetite-control centers.